These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 19264231

  • 21. [Molecular cytogenetic characteristics of chronic lymphocytic leukemia].
    Xu W, Li JY, Pan JL, Qiu HR, Shen YF, Xiao B, Chen LJ, Wu YF, Sheng RL, Xue YQ.
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):349-52. PubMed ID: 17044998
    [Abstract] [Full Text] [Related]

  • 22. 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.
    Struski S, Helias C, Gervais C, Audhuy B, Zamfir A, Herbrecht R, Lessard M.
    Cancer Genet Cytogenet; 2007 Apr 15; 174(2):151-60. PubMed ID: 17452258
    [Abstract] [Full Text] [Related]

  • 23. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Cavazzini F, Milani R, Minotto C, Tieghi A, Della Porta M, Agostini P, Tammiso E, Negrini M, Castoldi G.
    Haematologica; 2002 Jan 15; 87(1):44-51. PubMed ID: 11801464
    [Abstract] [Full Text] [Related]

  • 24. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
    Hwang Y, Lee JY, Mun YC, Seong CM, Chung WS, Huh J.
    Int J Lab Hematol; 2011 Jun 15; 33(3):299-304. PubMed ID: 21272268
    [Abstract] [Full Text] [Related]

  • 25. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J, Mikulenková D, Cermáková M, Polanská V, Michalová K, Marinov I, Campr V, Ransdorfová S, Marková J, Pavlistová L, Brezinová J, Sajdová J, Sponerová D, Volková Z, Benesová K, Cermák J, Vítek A, Cetkovský P.
    Neoplasma; 2006 Jun 15; 53(3):219-25. PubMed ID: 16652191
    [Abstract] [Full Text] [Related]

  • 26. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
    Aoun P, Zhou G, Chan WC, Page C, Neth K, Pickering D, Sanger W, Quinn-Laquer B, Watson P, Lynch JF, Lynch HT, Weisenburger DD.
    Am J Clin Pathol; 2007 Jan 15; 127(1):31-8. PubMed ID: 17145621
    [Abstract] [Full Text] [Related]

  • 27. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A, Van Dyke DL.
    Cancer Genet Cytogenet; 2004 Aug 15; 153(1):73-6. PubMed ID: 15325099
    [Abstract] [Full Text] [Related]

  • 28. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A, Bloehdorn J, Hafner S, Bühler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Döhner H, Stilgenbauer S.
    J Clin Oncol; 2006 Feb 20; 24(6):969-75. PubMed ID: 16418492
    [Abstract] [Full Text] [Related]

  • 29. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS.
    Int J Mol Med; 2007 Oct 20; 20(4):461-9. PubMed ID: 17786276
    [Abstract] [Full Text] [Related]

  • 30. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
    Cavazzini F, Rizzotto L, Sofritti O, Daghia G, Cibien F, Martinelli S, Ciccone M, Saccenti E, Dabusti M, Elkareem AA, Bardi A, Tammiso E, Cuneo A, Rigolin GM.
    Leuk Lymphoma; 2012 Jan 20; 53(1):83-8. PubMed ID: 21767243
    [Abstract] [Full Text] [Related]

  • 31. Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
    Parry-Jones N, Matutes E, Morilla R, Brito-Babapulle V, Wotherspoon A, Swansbury GJ, Catovsky D.
    Br J Haematol; 2007 Apr 20; 137(2):117-24. PubMed ID: 17391491
    [Abstract] [Full Text] [Related]

  • 32. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L, Ortega M, Ortuño F, González A, Losada J, Ojanguren J, Soler JA, Bergua J, Coll MD, Caballín MR.
    Cancer Genet Cytogenet; 2006 Nov 20; 171(1):57-64. PubMed ID: 17074592
    [Abstract] [Full Text] [Related]

  • 33. Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens.
    Flanagan MB, Sathanoori M, Surti U, Soma L, Swerdlow SH.
    Am J Clin Pathol; 2008 Oct 20; 130(4):620-7. PubMed ID: 18794056
    [Abstract] [Full Text] [Related]

  • 34. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
    Stilgenbauer S, Bullinger L, Lichter P, Döhner H, German CLL Study Group (GCLLSG). Chronic lymphocytic leukemia.
    Leukemia; 2002 Jun 20; 16(6):993-1007. PubMed ID: 12040431
    [Abstract] [Full Text] [Related]

  • 35. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
    Gerrie AS, Bruyere H, Chan MJ, Dalal CB, Ramadan KM, Huang SJ, Toze CL, Gillan TL.
    Cancer Genet; 2012 Oct 20; 205(10):523-7. PubMed ID: 22939229
    [Abstract] [Full Text] [Related]

  • 36. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U, Bock O, Vornhusen S, Jäger A, Büsche G, Lehmann U, Kreipe H.
    Hum Pathol; 2006 Sep 20; 37(9):1153-61. PubMed ID: 16938520
    [Abstract] [Full Text] [Related]

  • 37. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
    Glassman AB, Hayes KJ.
    Cancer Genet Cytogenet; 2005 Apr 01; 158(1):88-91. PubMed ID: 15771912
    [Abstract] [Full Text] [Related]

  • 38. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A, Stamatopoulos K, Tsompanakou A, Gaitatzi M, Kalogiannidis P, Anagnostopoulos A, Fassas A, Tsezou A.
    Cancer Genet Cytogenet; 2006 Jul 15; 168(2):109-19. PubMed ID: 16843100
    [Abstract] [Full Text] [Related]

  • 39. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
    El-Taweel M, Barin C, Cymbalista F, Eclache V.
    Cancer Genet Cytogenet; 2009 Nov 15; 195(1):37-42. PubMed ID: 19837267
    [Abstract] [Full Text] [Related]

  • 40. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
    Zenz T, Döhner H, Stilgenbauer S.
    Best Pract Res Clin Haematol; 2007 Sep 15; 20(3):439-53. PubMed ID: 17707832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.